Recipharm operations in Italy continue largely unaffected
The impact of COVID-19 on Recipharm’s worldwide operations continue to be monitored daily and to date we have noted limited effect. We anticipate that in the coming days some of our facilities located in the restricted zone of Italy may be operating at a lower capacity than normal. However, at this stage the businesses there continue to receive materials, manufacture and deliver routinely and are thus largely unaffected. In light of the COVID-19 situation, Recipharm AB will be publishing regular updates on its website providing the latest information about how the company is affected.